GNP Guia Naghi & Partners The Legal 500 – The Clients Guide to Law Firms
-1
archive,tag,tag-gnp,tag-182,theme-stockholm,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,woocommerce-no-js,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,side_area_over_content,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
4 June 2024 In AI, AIadvancements, AIinnovation, Allinsights, artificialintelligence, artificialintelligenceinsights, Digitaltransformation, Emergingtechnologies, EU AI Act, EU Law, europeanlegislation, Futureofwork, Innovativetech, Techtransformation, Techtrends

Roxana Barica – EDPB’s report on chatGPT Taskforce

Until 15 February 2024, OpenAI did not have an establishment in the European Union. Insofar, as no cooperation procedures according to the One-Stop-Shop (hereinafter “OSS”) mechanism under the GDPR could apply, the EDPB decided to establish a taskforce to foster cooperation and exchange information on

0
0
28 May 2024 In Competition, Competition Challenge, Decision, OnlineSales, Restriction

Patricia Avramescu – Acordurile de tip Non-Poach: recentele preocupări ale autorităților de concurență din UE au condus la publicarea unei noi politici a Comisiei Europene pe piața muncii

In recent years, European national competition authorities, including Romania, and well as the European Commission itself have begun to investigate and sanction non-poach agreements on the labour market, as well as practices of fixing salary thresholds. These investigations clearly show the current focus of the

0
0
10 May 2024 In AdministrativeDisputes, CaseLaw, Complaint, Dispute Resolution, EU Law, FairTrial, LegalFramework, PublicAuthorities, PublicDebate

Violeta Geru – Amazon case on interim relief following the application of DSA. Did the request for interim measures become even more burdensome for private entities seeking provisional relief? Will the national courts follow suit?

The dispute triggering the court proceedings The EU institutions developed in the recent years a framework for regulating the online services. As such, new obligations arise for online operators following the issuance of the e-commerce Directive[1], GDPR[2], P2B Regulation[3], DSA[4], DMA[5], Ominbus[6], etc. DSA is one

0
0
22 April 2024 In Consumer Protection, Green Claims, Green Washing, Unfair Practices

Alexandra Moisac – Directiva 2024/825 – Noi reguli impuse comercianților pentru combaterea dezinformării ecologice

În 26.03.2024 a intrat în vigoare Directiva 2024/825 de modificare a Directivelor 2005/29/CE și 2011/83/UE în ceea ce privește consolidarea rolului consumatorilor în vederea tranziției verzi printr-o mai bună protecție împotriva practicilor neloiale și o mai bună informare („Directiva privind consolidarea rolului consumatorilor” sau „Directiva”),

0
0
8 April 2024 In Data Protection, Data Protection Authority, GDPR, Right To Erasure

Sabina Vasile – Autoritatea de supraveghere a unui stat membru poate ordona, din oficiu, ștergerea datelor personale prelucrate ilegal

Prin hotărârea sa din 14 martie 2024, Curtea de Justiție a Uniunii Europene („CJUE”) a soluționat cauza C‑46/23, aducând clarificări cu privire la obligațiile pe care dreptul la ștergerea datelor le impune în sarcina operatorilor de date cu caracter personal. În sensul celor de mai sus,

0
0
25 March 2024 In Competition, europeanlaw, Fresh Perspectives, GNP, IP, PatentLitigation, Pharma, PharmaReport, VexatiousLitigation

Alexandra Stoicescu – Tales from the EC’s Latest Pharma Report: Where Patent Rights End and Abuse of Dominance Begins

On 26 January 2024, the European Commission (the „EC”) published a comprehensive report (the „Report”) aimed to outline the recent competition enforcement in the pharmaceutical sector carried out by the EC and the national competition authorities (the „NCAs”) from 2018 to 2022. This Report highlights

0
0
21 March 2024 In Fresh Perspectives, GNP, Life Sciences, MaximalPrices, Medicines, Pharma, Pharma, PHARMA & REGULATORY, Pricing, Regulatory

Alina Stoica – Metodologia de aprobare a prețurilor la medicamente în prag de schimbare

Principiile generale privind metodologia de calcul a prețurilor maximale pentru medicamentele eliberate cu prescripție medicală au rămas neschimbate încă din 2009, respectiv, regula celui mai mic preț din țările de comparație (i.e., prețul aprobat în România nu poate depăși cel mai mic preț al aceluiași

0
0